ord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at
www.corcell.com. For investor information, visit
www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
'/>"/>SOURCE Cord Blood America, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Cord Blood America Announces 2008 Financial Results2.
Metametrix Introduces the New TRIAD(SM) Bloodspot Profile3.
China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.4.
Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome5.
BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University6.
Cord Blood America Sees Significant Positives in President Obamas Lifting of Stem Cell Funding Restrictions7.
Cord Blood America Restructures Debt; Projects to be Cash Flow Positive8.
In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting9.
Cord Blood Announces $1 Million Reduction in Long Term Debt10.
In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors11.
ERT (eResearchTechnology, Inc.) and Integrium, LLC Form Alliance to Deliver Integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring Services